Robert Wilson

Robert Wilson is an accomplished professional in the fields of preclinical and clinical pharmacology, currently serving as the Director of Preclinical and Clinical Pharmacology at Healx since March 2022. Previously, Robert held the position of Senior Regulatory Consultant at DLRC Regulatory Consultancy from September 2019 to March 2022 and worked at GSK for over two decades, where responsibilities included managerial roles in clinical pharmacology modeling and simulation, particularly for respiratory projects and early-phase study designs. Earlier experience includes a role as a behavioural pharmacologist at MSD, beginning in 1997. Robert holds a degree in Pharmacology from the University of Liverpool, obtained in June 1996.